Nov 5
MARKSANS · Marksans Pharma Limited
Market Cap
144.37B INR
Shares
453.29M
Volume · Nov 13
1.75M
Avg daily vol (3M)
2.43M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close318.50 INR
Open323.70 INR
Day315.50–328.70 INR
52W close156.89–347.60 INR
Avg vol 30d1.5M
Last earningsNov 5, 2026
DataJan 2020–Nov 2026
Quarterly results
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 156.89 INR
Now 318.50 INR · 85%
Range high 347.60 INR
vs 200-day avg +29%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XNSE:MARKSANS | +4.9% | +3.5% | +50.3% | +4.0% | +76.7% |
Exchange listing
- Market
- XNSE
- Ticker
- MARKSANS
- ISIN
- INE750C01026
- Security
- Ordinary share
- Trading currency
- INR
Company
- Investor relations
- https://www.marksanspharma.com/disclosure-46-sebi-lodr.html
Other listings of this company
Share classes and depositary receipts can have different prices and dividends.
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2026-08-20 | 0.90 INR |
| 2025-08-01 | 0.80 INR |
| 2024-09-17 | 0.60 INR |
| 2023-06-07 | 0.50 INR |
| 2022-08-19 | 0.25 INR |
| 2021-09-15 | 0.25 INR |
| 2020-09-22 | 0.10 INR |
| 2019-09-19 | 0.05 INR |
| 2018-09-19 | 0.05 INR |
| 2017-09-19 | 0.05 INR |
| 2016-09-22 | 0.12 INR |
| 2015-09-23 | 0.12 INR |
| 2014-09-18 | 0.10 INR |
Upcoming investor events
No upcoming investor events are listed for this company yet.
Earnings calls
-
Earnings call · Q2 2027 2026-11-05 Audio TranscriptEarnings Call for the Quarter Ended September 30, 2026
-
Earnings call · Q1 2027 2026-08-13 Audio TranscriptEarnings Call
-
Earnings call · Q4 2026 2026-05-27 Audio TranscriptMarksans Pharma Limited Q4 FY26 Earnings Conference Call
-
Earnings call · Q3 2026 2026-02-06 Audio Transcript“Marksans Pharma Limited Q3 FY26 Earnings Conference Call”